<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with Cushingâ€™s syndrome (CS) may experience delays in diagnostic evaluation and surgical management, as well as interruptions in the continuous supply of medication during the COVID-19 pandemic, with disastrous consequences. Thus, it is imperative for the teams managing these patients to identify and address these issues [
 <xref rid="CIT0073" ref-type="bibr">73</xref>].
</p>
